Octanols < Octreotide < Oculomotor Muscles

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 619.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000447 (2013)		Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.
000582 (2013)		Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model.
000609 (2013)		Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer.
000663 (2013)		Diffuse lung uptake of 111In octreotide from chronic emphysema.
000685 (2012)		Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.
000745 (2013)		Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
000754 (2013)		Contemporary approach to diagnosis and treatment of neuroblastoma.
000829 (2013)		Tumor localization and biochemical response to cure in tumor-induced osteomalacia.
000895 (2012)		Orbital carcinoid metastasis: diverse presentations and value of indium-octreotide imaging.
000936 (2013)		Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma.
000960 (2013)		Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.
000B00 (2012)		Nuclear medicine imaging of neuroendocrine tumours.
000B05 (2012)		Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
000B17 (2012)		One single-time-point kidney uptake from OctreoScan correlates with number of desintegrations measured over 72 hours and calculated for the 6.7 hours half-life nuclide (177)Lu.
000B82 (2012)		Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
000D18 (2012)		Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.
000D25 (2012)		Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?
000F15 (2012)		¹¹¹In OctreoScan SPECT-MRI fusion for the detection of a pancreatic insulinoma.
000F63 (2012)		Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
000F73 (2012)		First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment.
001009 (2011)		[Experimental study of indium-111 labeled octreotide application for radionuclide diagnostics of tumors with high expression of somatostatin receptors].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Octreotide" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Octreotide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Octreotide
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024